14 results on '"Price, Victoria E."'
Search Results
2. Preventing and treating infections in children with asplenia or hyposplenia.
- Author
-
Salvadori, Marina I and Price, Victoria E
- Subjects
- *
ANTIBIOTIC prophylaxis , *INFECTION prevention , *MALARIA prevention , *HAEMOPHILUS diseases , *IMMUNIZATION , *MENINGOCOCCAL vaccines , *AGE distribution , *PEDIATRICS , *SEPSIS , *SPLEEN diseases , *SPLENECTOMY , *DISEASE complications , *PREVENTION , *VACCINATION , *DISEASE risk factors , *THERAPEUTICS - Abstract
Children with asplenia or hyposplenia are at risk of developing overwhelming sepsis. Health care providers caring for children with asplenia should ensure the best outcomes by using preventive strategies that focus on parent and patient education, immunization, antibiotic prophylaxis and aggressive management of suspected infection. The present position statement offers current guidance on each of these issues and replaces a previous CPS statement, 'Prevention and therapy of bacterial infections for children with asplenia or hyposplenia', published in 1999. [ABSTRACT FROM AUTHOR]
- Published
- 2014
3. La prévention et le traitement des infections chez les enfants présentant une asplénie ou une hyposplénie.
- Author
-
Salvadori, Marina I and Price, Victoria E
- Subjects
- *
SERIAL publications - Published
- 2014
- Full Text
- View/download PDF
4. Shakespeare and Popular Music.
- Author
-
Price, Victoria E.
- Subjects
- *
NONFICTION - Abstract
The article reviews the book "Shakespeare and Popular Music," by Adam Hansen.
- Published
- 2012
- Full Text
- View/download PDF
5. The Burgher and the Whore: Prostitution in Early Modern Amsterdam - By Lotte van de Pol.
- Author
-
PRICE, VICTORIA E.
- Subjects
- *
SEX work , *NONFICTION - Abstract
A review of the book "The Burgher and the Whore: Prostitution in Early Modern Amsterdam," by Lotte Van de Pol and translated by Liz Waters is presented.
- Published
- 2012
- Full Text
- View/download PDF
6. Caractéristiques des hospitalisations au Canada d'enfants ayant contracté une infection aiguë par le SRAS-CoV-2 en 2020.
- Author
-
Drouin, Olivier, Hepburn, Charlotte Moore, Farrar, Daniel S., Baerg, Krista, Chan, Kevin, Cyr, Claude, Donner, Elizabeth J., Embree, Joanne E., Farrell, Catherine, Forgie, Sarah, Giroux, Ryan, Kang, Kristopher T., King, Melanie, Laffin, Melanie, Luu, Thuy Mai, Orkin, Julia, Papenburg, Jesse, Pound, Catherine M., Price, Victoria E., and Purewal, Rupeena
- Abstract
Résumé: Contexte: Les facteurs de risque de complications graves de l'infection par le SRAS-CoV-2 n'ont pas été bien établis chez les enfants. Nous avons voulu décrire les hospitalisations pédiatriques associées au SRAS-CoV-2 au Canada et identifier les facteurs de risque de maladie grave. Méthodes: Nous avons procédé à une étude prospective nationale en utilisant l'infrastructure du Programme canadien de surveillance pédiatrique (PCSP). Les hospitalisations d'enfants ayant contracté une infection par le SRAS-CoV-2 confirmée en laboratoire de microbiologie ont été rapportées du 8 avril au 31 décembre 2020 au moyen de questionnaires hebdomadaires en ligne distribués au réseau du PCSP, qui compte plus de 2800 pédiatres. Nous avons catégorisé les hospitalisations comme suit : liées à la COVID-19, infections découvertes fortuitement, ou hospitalisations pour des raisons sociales ou de contrôle des infections, et dégagé les facteurs de risque associés à la gravité de la maladie chez les patients hospitalisés. Résultats: Sur les 264 hospitalisations d'enfants ayant contracté le SRAS-CoV-2 au cours de la période de l'étude de 9 mois, 150 (56,8 %) ont été associées à la COVID-19 et 100 (37,9 %) étaient des cas découverts fortuitement (admission pour d'autres raisons et découverte fortuite du SRAS-CoV-2 par dépistage positif). Les nourrissons (37,3 %) et les adolescents (29,6 %) représentaient la majorité des cas. Parmi les hospitalisations liées à la COVID-19, 52 patients (34,7 %) étaient atteints d'une forme grave de la maladie, dont 42 (28,0 % des cas liés à la COVID-19) ont eu besoin d'une forme d'assistance respiratoire ou hémodynamique, et 59 (39,3 %) présentaient au moins 1 comorbidité sous-jacente. Les enfants atteints d'obésité, de maladies neurologiques chroniques ou de maladies pulmonaires chroniques, à l'exclusion de l'asthme, étaient plus susceptibles de présenter une forme grave ou critique de la COVID-19. Interprétation: Parmi les enfants hospitalisés au Canada chez lesquels on a diagnostiqué une infection par le SRAS-CoV-2 au début de la pandémie de COVID-19, la découverte fortuite du SRAS-CoV-2 a été fréquente. Chez les enfants hospitalisés pour une COVID-19 aiguë, l'obésité et les comorbidités neurologiques et respiratoires ont été associées à une gravité accrue. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
7. Characteristics of children admitted to hospital with acute SARS-CoV-2 infection in Canada in 2020.
- Author
-
Drouin, Olivier, Hepburn, Charlotte Moore, Farrar, Daniel S., Baerg, Krista, Chan, Kevin, Cyr, Claude, Donner, Elizabeth J., Embree, Joanne E., Farrell, Catherine, Forgie, Sarah, Giroux, Ryan, Kang, Kristopher T., King, Melanie, Laffin, Melanie, Luu, Thuy Mai, Orkin, Julia, Papenburg, Jesse, Pound, Catherine M., Price, Victoria E., and Purewal, Rupeena
- Subjects
- *
SARS-CoV-2 , *CHILDREN'S hospitals , *COVID-19 pandemic , *NEUROLOGICAL disorders , *COVID-19 , *INFECTION - Abstract
Background: Risk factors for severe outcomes of SARS-CoV-2 infection are not well established in children. We sought to describe pediatric hospital admissions associated with SARS-CoV-2 infection in Canada and identify risk factors for more severe disease.Methods: We conducted a national prospective study using the infrastructure of the Canadian Paediatric Surveillance Program (CPSP). Cases involving children who were admitted to hospital with microbiologically confirmed SARS-CoV-2 infection were reported from Apr. 8 to Dec. 31 2020, through weekly online questionnaires distributed to the CPSP network of more than 2800 pediatricians. We categorized hospital admissions as related to COVID-19, incidental, or for social or infection control reasons and determined risk factors for disease severity in hospital.Results: Among 264 hospital admissions involving children with SARS-CoV-2 infection during the 9-month study period, 150 (56.8%) admissions were related to COVID-19 and 100 (37.9%) were incidental infections (admissions for other reasons and found to be positive for SARS-CoV-2 on screening). Infants (37.3%) and adolescents (29.6%) represented most cases. Among hospital admissions related to COVID-19, 52 (34.7%) had critical disease, 42 (28.0%) of whom required any form of respiratory or hemodynamic support, and 59 (39.3%) had at least 1 underlying comorbidity. Children with obesity, chronic neurologic conditions or chronic lung disease other than asthma were more likely to have severe or critical COVID-19.Interpretation: Among children who were admitted to hospital with SARS-CoV-2 infection in Canada during the early COVID-19 pandemic period, incidental SARS-CoV-2 infection was common. In children admitted with acute COVID-19, obesity and neurologic and respiratory comorbidities were associated with more severe disease. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
8. Patterns of joint damage in severe haemophilia A treated with prophylaxis.
- Author
-
Goren, Rachel, Pullenayegum, Eleanor, Blanchette, Victor S., Dover, Saunya, Carcao, Manuel, Israels, Sara J., Chan, Anthony, Rivard, Georges E., Steele, MacGregor, Cloutier, Stéphanie, Klaassen, Robert J., Sinha, Roona, Price, Victoria E., Laferriere, Nicole, Paradis, Elizabeth, Wu, John K., and Feldman, Brian M.
- Subjects
- *
BLOOD coagulation factor VIII , *BLOOD groups , *HEMOPHILIA , *MEDICAL personnel , *JOINTS (Anatomy) , *VON Willebrand disease - Abstract
Objective: The primary objective of this study was to assess whether there are different patterns (classes) of joint health in young boys with severe haemophilia A (SHA) prescribed primary tailored prophylaxis. We also assessed whether age at first index joint bleed, blood group, FVIII gene abnormality variant, factor VIII trough level, first‐year bleeding rate and adherence to the prescribed prophylaxis regimen significantly predicted joint damage trajectory, and thus class membership. Methods: Using data collected prospectively as part of the Canadian Hemophilia Primary Prophylaxis Study (CHPS), we implemented a latent class growth mixture model technique to determine how many joint damage classes existed within the cohort. We used a multinomial logistic regression to predict the odds of class membership based on the above predictors. We fitted a survival model to assess whether there were differences in the rate of dose escalation across the groups. Results: We identified three distinct classes of trajectory: persistently low, moderately increasing and rapidly increasing joint scores. By multinomial regression, we found that only age at first index joint bleed predicted rapidly increasing joint scores. The rapidly increasing joint score class group moved through dose escalation significantly faster than the other two groups. Conclusions: Using tailored prophylaxis, boys with SHA follow one of three joint health trajectories. By using knowledge of disease trajectories, clinicians may be able to adjust treatment according to a subject's predicted long‐term joint health and institute cost‐effective programmes of prophylaxis targeted at the individual subject level. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
9. Waning Vaccine Immunity and Vaccination Responses in Children Treated for Acute Lymphoblastic Leukemia: A Canadian Immunization Research Network Study.
- Author
-
Top, Karina A, Vaudry, Wendy, Morris, Shaun K, Pham-Huy, Anne, Pernica, Jeffrey M, Tapiéro, Bruce, Gantt, Soren, Price, Victoria E, Rassekh, S Rod, Sung, Lillian, McConnell, Athena, Rubin, Earl, Chawla, Rupesh, and Halperin, Scott A
- Subjects
- *
LYMPHOBLASTIC leukemia treatment , *CONFIDENCE intervals , *IMMUNE response , *IMMUNIZATION , *IMMUNOCOMPETENT cells , *IMMUNOSUPPRESSION , *INFLUENZA vaccines , *MEDICAL cooperation , *PNEUMOCOCCAL vaccines , *RESEARCH , *SEROTYPES , *ODDS ratio , *CHILDREN - Abstract
Background There is no uniform guideline for postchemotherapy vaccination of children with acute lymphoblastic leukemia (ALL). We evaluated waning immunity to 14 pneumococcal serotypes, pertussis toxin (PT), tetanus toxoid (TT) and varicella, and immunogenicity of postchemotherapy diphtheria, tetanus, pertussis, hepatitis B, polio, and Haemophilus influenzae type b (DTaP-IPV-Hib) and pneumococcal vaccination among previously vaccinated children treated for ALL. Methods This was a multicenter trial of children with ALL enrolled 4–12 months postchemotherapy completion. Exclusion criteria included: infant ALL, relapsed ALL, and stem cell transplant recipients. Immunocompetent children were recruited as controls. Postchemotherapy participants received DTaP-IPV-Hib and 13-valent pneumococcal conjugate vaccine (PCV13) concurrently, followed by 23-valent pneumococcal polysaccharide vaccine (PPV23) 2 months later. Serology was measured at baseline, 2 and 12 months postvaccination. Adverse events were captured via surveys. Results At enrollment, postchemotherapy participants (n = 74) were less likely than controls (n = 78) to be age-appropriately immunized with DTaP (41% vs 89%, P < .001) and PCV (59% vs 79%, P = .008). Geometric mean concentrations (GMCs) to TT, PT, PCV serotypes, and varicella were lower in postchemotherapy participants than controls after adjusting for previous vaccine doses (P < .001). Two months postvaccination, GMCs to TT, PT, and PCV serotypes increased from baseline (P < .001 for all antigens) and remained elevated at 12 months postvaccination. Antibody levels to PPV23 serotypes also increased postvaccination (P < .001). No serious adverse events were reported. Conclusions Children treated for ALL had lower antibody levels than controls against pneumococcal serotypes, tetanus, pertussis, and varicella despite previous vaccination. Postchemotherapy vaccination with DTaP-IPV-Hib, PCV13, and PPV23 was immunogenic and well tolerated. Children with ALL would benefit from systematic revaccination postchemotherapy. Clinical Trials Registration NCT02447718. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
10. Measuring the impact of changing from standard half‐life (SHL) to extended half‐life (EHL) FVIII prophylaxis on health‐related quality of life (HRQoL) in boys with moderate/severe haemophilia A: Lessons learned with the CHO‐KLAT tool
- Author
-
Carcao, Manuel, Zunino, Laura, Young, Nancy L., Dover, Saunya, Bouskill, Vanessa, Hilliard, Pamela, Price, Victoria E., and Blanchette, Victor S.
- Subjects
- *
HEMOPHILIA , *QUALITY of life , *PREVENTIVE medicine - Abstract
Introduction: In many countries, there is a shift from standard half‐life (SHL) to extended half‐life (EHL) clotting factor concentrates (CFCs). Aim: To describe the experience of switching from SHL to an EHL FVIII CFC and the impact of this on frequency of infusions, factor consumption, bleeding rates and HRQoL using the Canadian Hemophilia Kids' Life Assessment Tool (CHO‐KLAT). Methods: A retrospective chart review was conducted at a single haemophilia treatment centre in 2018 that included boys (ages: 4‐18 years) with moderate/severe haemophilia A, without inhibitors, who switched from a SHL to an EHL FVIII CFC in the previous 2 years and for whom HRQoL data were available. Results: The study cohort comprised 38 boys [mean (SD) age: 11.0 (3.4) years] with moderate (n = 5)/severe (n = 33) haemophilia A. The switch was associated with a 33% reduction in the number of weekly infusions from a median of 3.5 to 2.3 (P <.0001) and a 17% reduction in median FVIII consumption from 103 IU/kg/wk to 85.5 IU/kg/wk (P =.004). There was no significant change in annualized joint bleed rates or in CHO‐KLAT scores. Conclusions: Despite documenting several benefits of switching to EHL FVIII (less infusions, lower factor consumption with no increase in bleeding), our study did not demonstrate any improvement in HRQoL. We conclude that either the current CHO‐KLAT tool is not optimized to measure burden of treatment administration in boys with low bleed rates switching from SHL to EHL FVIII CFCs or that a reduction of 1.2 infusions/week does not result in a meaningful change in HRQoL. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
11. Children of the Queen's Revels: A Jacobean Theatre Repertory/Drama at the Courts of Queen Henrietta Maria.
- Author
-
Price, Victoria E.
- Subjects
- *
NONFICTION - Abstract
The article reviews the books "Children of the Queen's Revels: A Jacobean Theatre Repertory," by Lucy Munro and "Drama at the Courts of Queen Henrietta Maria," by Karen Britland.
- Published
- 2007
- Full Text
- View/download PDF
12. Privacy, Playreading & Women's Closet Drama 1550-1700.
- Author
-
Price, Victoria E.
- Subjects
- *
CLOSET drama , *NONFICTION - Abstract
The article reviews the book "Privacy, Playreading, and Women's Closet Drama, 1550-1700," by Marta Straznicky.
- Published
- 2005
- Full Text
- View/download PDF
13. The Cambridge Companion to Christopher Marlowe.
- Author
-
Price, Victoria E.
- Subjects
- *
THEATER , *NONFICTION - Abstract
Reviews the book "The Cambridge Companion to Christopher Marlowe," edited by Patrick Cheney.
- Published
- 2005
- Full Text
- View/download PDF
14. Routine bone marrow examination in the initial evaluation of paediatric Hodgkin lymphoma: the Canadian perspective.
- Author
-
Simpson, C. David, Jun Gao, Fernandez, Conrad V., Yhap, Margaret, Price, Victoria E., and Berman, Jason N.
- Subjects
- *
HODGKIN'S disease , *LYMPHOMAS , *ONCOLOGISTS , *IMMUNE system ,BONE marrow examination - Abstract
Bone marrow examination (BME) in paediatric Hodgkin lymphoma (HL) was evaluated, as evidence from adult HL suggests it may be unnecessary. An internet-based survey was used to examine the practice of Canadian paediatric oncologists regarding BME in children and the impact of routine BME was evaluated in patients with HL treated at our institution. Sixteen of 17 paediatric oncology centres were represented. Forty-three percent of eligible doctors completed the survey. Routine BME for stages III and IV disease was consistent nationally. By contrast, 54% and 70% of respondents reported performing routine BME for stages I and II HL respectively. Respondents were more likely to report performing routine BME in low-stage HL if trained outside Canada ( P = 0·04, stage I; P = 0·07, stage II) or practicing at smaller centres ( P = 0·05, stage I; P = 0·03, stage II). At our institution, 62 patients were eligible for analysis. Only four patients (6·5%) had a positive BME. Anaemia was the only significant risk factor ( P = 0·006). No patient with otherwise low stage was found to have marrow involvement. Comparison of staging with and without BME demonstrated no significant difference to final risk classification. BME in paediatric patients with low-stage HL has extremely low yield and may be unnecessary. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.